Sherrie Pietranico-Cole

Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia

Martha J. Kelly, Sherrie Pietranico-Cole, J. Douglas Larigan et al. · Journal of Medicinal Chemistry · 2014 · 205 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Central Thyroid Axis +16

Modulation of Receptor and Receptor Subtype Affinities Using Diastereomeric and Enantiomeric Monosaccharide Scaffolds as a Means to Structural and Biological Diversity. A New Route to Ether Synthesis

Ralph Hirschmann, John Hynes, Maria A. Cichy-Knight et al. · Journal of Medicinal Chemistry · 1998 · 108 citations · Full text

2‐Phenoxy‐nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)

Rainer E. Martin, Caterina Bissantz, Olivier Gavelle et al. · ChemMedChem · 2012 · 39 citations

Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists

Paul Gillespie, Robert A. Goodnow, Goutam Saha et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 13 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +6